Controlled release carvedilol compositions
US8449914B2 · kind B2 · utility
11Cited by
21References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 13, 2008 |
| Grant date | May 28, 2013 |
| Priority date | — |
| Expiry date | Oct 18, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/403
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A controlled release pharmaceutical composition for oral use comprising carvedilol. The composition releases carvedilol after oral administration to a mammal, including a human, in such a manner that a prolonged residence of carvedilol is obtained in the circulatory system compared with the known compositions of carvedilol. Furthermore, a composition according to the present invention makes available to the body a suitable plasma concentration of one or both of the enantiomeric species, namely R(+) and/or S(−) carvedilol for obtaining the desired therapeutic effect.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.